CA
NZ
UK
AU
IND
US
…
ICG plc is a private equity firm specializing in direct and fund of fund investments. Within direct it specializes in private debt, venture debt, credit and equity investments. It invests in middle market, mature, growth capital, reinvestment, industry consolidations, bridge financing, restructuring of a shareholder base, acquisitions, public to private transactions with or without private equity backing, leveraged and acquisition finance, leveraged credit, partnership equity, management buyouts and management buyins, secondary (direct) and secondary (indirect) investments, traditional, development capital, public quoted company finance, off-balance-sheet finance, refinancing and recapitalizations, and pre-IPO financing. The firm does not invest in property companies, early-stage funds or start-ups. Within fund of fund, it specializes in secondary investments. It also invests in the debt, fixed income and alternate asset markets. The firm's alternative capital solutions invest in mid-market companies, in Europe, the United States and Asia Pacific. It invests in corporate businesses through private debt, senior, junior and sub-ordinate debt, mezzanine, structured loans and equity in Europe, Asia Pacific and North America. The firm prefers to invest in all sectors with a focus on insurance, energy, materials, environmental and facilities services, human resources and employment services, leisure products, consumer staples, healthcare, infrastructure services, media and entertainment, utilities, equity real estate investment trusts, education and childcare. The firm seeks to invest in life sciences in Western Europe and the United States. The firm invests in a diversified portfolio of senior secured loans to established companies in Australia and New Zealand. The firm focuses on European senior direct lending, investing in a diversified portfolio of mid-market and upper mid-market corporate borrowers in Western and Northern Europe. The firm is focused on limited partnership liquidity solutions in North America and E
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 530.50M | 530.80M | 251.00M | 565.90M | 509.50M |
| Minority interest | 0.00M | -1.00M | 2.20M | 1.70M | -3.90M |
| Net income | 451.20M | 473.40M | 280.60M | 526.80M | 457.10M |
| Selling general administrative | 97.30M | 76.40M | 65.60M | 101.00M | 83.80M |
| Selling and marketing expenses | - | 296.20M | 259.50M | - | - |
| Gross profit | 951.40M | 963.70M | 579.10M | 934.70M | 656.80M |
| Reconciled depreciation | 17.80M | 18.00M | 18.20M | 19.50M | 19.20M |
| Ebit | 530.50M | 580.70M | 311.20M | 617.60M | 569.70M |
| Ebitda | 548.30M | 598.70M | 329.40M | 637.10M | 585.30M |
| Depreciation and amortization | 17.80M | 18.00M | 18.20M | 19.50M | 15.60M |
| Operating income | 530.50M | 598.70M | 253.50M | 619.00M | 505.60M |
| Other operating expenses | 459.90M | 372.70M | 599.00M | 345.60M | 162.90M |
| Interest expense | 39.00M | 44.90M | 59.90M | 47.40M | 53.50M |
| Tax provision | 79.30M | 62.40M | 29.40M | 31.10M | 48.50M |
| Interest income | 0.00M | 21.60M | 15.50M | 0.00M | 0.00M |
| Net interest income | -39.00M | -23.30M | -44.40M | -47.40M | -53.50M |
| Income tax expense | 79.30M | 62.40M | 29.40M | 31.10M | 48.50M |
| Total revenue | 990.40M | 981.70M | 599.00M | 989.50M | 672.40M |
| Total operating expenses | 420.90M | 372.70M | 599.00M | 345.60M | 162.90M |
| Cost of revenue | 39.00M | 18.00M | 18.20M | 18.10M | 15.60M |
| Total other income expense net | - | -67.90M | -2.50M | -53.10M | -18.50M |
| Net income from continuing ops | 451.20M | 468.40M | 221.60M | 534.30M | 461.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 9342.60M | 9122.10M | 9052.50M | 8872.50M | 7463.90M |
| Intangible assets | 11.30M | 10.70M | 10.60M | 12.80M | 17.20M |
| Other current assets | 10.60M | -1466.20M | -1278.30M | -1395.10M | -919.60M |
| Total liab | 6851.70M | 6822.40M | 7007.30M | 6870.70M | 5841.70M |
| Total stockholder equity | 2491.00M | 2301.90M | 2019.80M | 1971.80M | 1617.20M |
| Other current liab | -56.90M | -304.40M | -418.80M | -241.30M | -314.60M |
| Common stock | 77.30M | 77.30M | 77.30M | 77.30M | 77.20M |
| Capital stock | 77.30M | 77.30M | 77.30M | 77.30M | 77.20M |
| Retained earnings | 2203.00M | 1987.50M | 1742.60M | 1714.00M | 1362.70M |
| Good will | 4.30M | 4.30M | 4.30M | 4.30M | 4.30M |
| Other assets | - | -7474.00M | 1071.20M | 548.20M | 365.30M |
| Cash | 604.80M | 990.00M | 550.00M | 761.50M | 296.90M |
| Total current liabilities | 554.50M | 3.30M | 471.40M | 434.40M | 427.30M |
| Current deferred revenue | - | -259.30M | 407.10M | 226.80M | 311.10M |
| Net debt | 5501.20M | -627.40M | 5559.40M | 5256.60M | 4907.40M |
| Short term debt | - | 259.30M | 64.30M | 207.60M | 116.20M |
| Short long term debt total | 6106.00M | 6127.90M | 6109.40M | 6018.10M | 5204.30M |
| Other stockholder equity | 210.70M | 102.10M | 77.50M | 87.30M | 98.00M |
| Total current assets | 1076.90M | 990.00M | 809.10M | 1132.90M | 566.30M |
| Long term investments | 7756.00M | 7474.00M | 7069.10M | 7113.90M | 6443.80M |
| Short term investments | - | 362.60M | 4.70M | - | 64.60M |
| Net receivables | 461.50M | 383.90M | 259.10M | 371.40M | 269.40M |
| Inventory | - | 1082.30M | 1278.30M | 1395.10M | 919.60M |
| Accounts payable | 554.50M | 525.90M | 468.30M | 434.40M | 427.30M |
| Accumulated other comprehensive income | - | 135.00M | 122.40M | 93.20M | 79.30M |
| Non currrent assets other | 8117.50M | -7568.20M | -17.60M | -25.00M | -2.90M |
| Non current assets total | 8265.70M | 15606.10M | 7172.20M | 7191.40M | 6532.30M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | 22.40M | 71.50M | 130.80M | 45.50M | 64.70M |
| Total cashflows from investing activities | 276.10M | 71.50M | 130.80M | 45.50M | 64.70M |
| Net borrowings | -253.30M | -59.10M | -201.40M | 297.90M | - |
| Total cash from financing activities | -524.60M | -282.50M | -476.70M | 111.30M | -653.30M |
| Net income | 530.50M | 530.80M | 251.00M | 565.40M | 509.50M |
| Change in cash | -129.80M | 32.50M | -34.30M | 410.60M | -505.70M |
| Begin period cash flow | 990.00M | 957.50M | 991.80M | 581.20M | 1086.90M |
| End period cash flow | 860.20M | 990.00M | 957.50M | 991.80M | 581.20M |
| Total cash from operating activities | 136.10M | 255.90M | 291.60M | 243.40M | 111.00M |
| Depreciation | 17.80M | 18.00M | 18.20M | 19.50M | 19.20M |
| Other cashflows from investing activities | 22.40M | 31.50M | -63.50M | 18.10M | 36.70M |
| Dividends paid | 228.90M | 223.40M | 236.40M | 165.70M | 150.90M |
| Change to account receivables | -87.60M | -88.70M | -12.00M | -32.50M | -35.40M |
| Sale purchase of stock | -42.40M | 0.00M | -38.90M | -20.90M | 0.00M |
| Other cashflows from financing activities | - | -8.40M | 130.80M | 45.50M | 64.70M |
| Capital expenditures | 6.60M | 9.50M | 11.20M | 7.80M | 10.80M |
| Change in working capital | -75.30M | -106.40M | -217.70M | -59.90M | 51.80M |
| Stock based compensation | - | 43.90M | 39.50M | 29.60M | 26.90M |
| Other non cash items | -336.90M | -230.40M | -395.00M | -351.30M | -247.50M |
| Free cash flow | 129.50M | 246.40M | 280.40M | 235.60M | 100.20M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ICG Intermediate Capital Group PLC |
9.00 0.50% |
1808.00 | 8.03 | 10.75 | 4.31 | 1.76 | 4.02 | 9.45 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 | - |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 | - |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 | 6.56 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 | - |
ICG plc is a private equity firm specializing in direct and fund of fund investments. Within direct it specializes in private debt, venture debt, credit and equity investments. It invests in middle market, mature, growth capital, reinvestment, industry consolidations, bridge financing, restructuring of a shareholder base, acquisitions, public to private transactions with or without private equity backing, leveraged and acquisition finance, leveraged credit, partnership equity, management buyouts and management buyins, secondary (direct) and secondary (indirect) investments, traditional, development capital, public quoted company finance, off-balance-sheet finance, refinancing and recapitalizations, and pre-IPO financing. The firm does not invest in property companies, early-stage funds or start-ups. Within fund of fund, it specializes in secondary investments. It also invests in the debt, fixed income and alternate asset markets. The firm's alternative capital solutions invest in mid-market companies, in Europe, the United States and Asia Pacific. It invests in corporate businesses through private debt, senior, junior and sub-ordinate debt, mezzanine, structured loans and equity in Europe, Asia Pacific and North America. The firm prefers to invest in all sectors with a focus on insurance, energy, materials, environmental and facilities services, human resources and employment services, leisure products, consumer staples, healthcare, infrastructure services, media and entertainment, utilities, equity real estate investment trusts, education and childcare. The firm seeks to invest in life sciences in Western Europe and the United States. The firm invests in a diversified portfolio of senior secured loans to established companies in Australia and New Zealand. The firm focuses on European senior direct lending, investing in a diversified portfolio of mid-market and upper mid-market corporate borrowers in Western and Northern Europe. The firm is focused on limited partnership liquidity solutions in North America and E
| Name | Title | Year Born |
|---|---|---|
| Mr. Benoit Laurent Pierre Durteste | CEO, Chief Investment Officer & Executive Director | 1968 |
| Mr. David Christopher Michael Bicarregui | CFO & Executive Director | 1975 |
| Ms. Antje Hensel-Roth | Executive Director and Chief People & External Affairs | 1979 |
| Mr. Krysto Nikolic | Senior MD & Global Head of Real Estate | NA |
| Ms. Sarah Faulkner | Chief Operating Officer | NA |
| Mr. Sridhar Bearelly J.D. | Head of Alternative Credit & Chief Investment Officer of Alternative Credit | NA |
| Mr. Chris Hunt | Head of Corporate Development & Shareholder Relation | NA |
| Mr. Andrew Lewis | Global Head of Legal & Company Secretary | 1979 |
| Ms. Clare Glynn | Head of Corporate Communications | NA |
| Mr. Hadj Djemaï | Head of Southern Europe & European Corporate | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.26%
Communication Services
-0.18%
Consumer Cyclical
-0.36%
Consumer Defensive
+0.07%
Energy
-0.01%
Financial Services
-0.26%
Financials
-2.20%
Healthcare
-0.55%
Industrials
-0.08%
Real Estate
-0.33%
Technology
-0.70%
Utilities
-0.41%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...